<?xml version="1.0"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta name="generator"
    content="HTML Tidy for FreeBSD (vers 1st April 2002), see www.w3.org" />

    <title>Balanitis Xerotica Obliterans (BXO) - Lichen Sclerosus
    et Atrophicus (LSA)</title>
    <meta name="robots" content="index, follow" />
    <meta name="keywords"
    content="BXO, LSA, balanitis xerotica obliterans, kraurosis, kraurosis penii, lichen sclerosus, lichen sclerosis, et atrophicus, conservative treatment, penis, foreskin, prepuce, glans penis, glans, urethra, circumcision, boys, males, men, testosterone propionate, testosterone propionate, corticocosteroid, clobetasol, carbon dioxide laser, antibiotics, history, symptoms, men's health, male health" />
    <meta name="description"
    content="An index of material on the conservative treatment of balanitis xerotica obliterans (BXO)." />
    <style type="text/css">
/*<![CDATA[*/
<!--
body
{
background-color: white;
color: black;
}
div.corpus
{
margin-left: 10%;
margin-right: 10%;
}
ol
{
font-size: 11pt;
}
p.navlink
{
text-align: center;
}
span.yellow
{
background-color: #ff9;
}
sup
{
font-size: 8pt;
}
-->
/*]]>*/
    </style>
  </head>

  <body bgcolor="white">
    <div class="corpus">
      <a href="/"><img src="/gif/CIRP0.png" alt="logo" /></a> 

      <h2>Balanitis Xerotica Obliterans: Conservative Treatment
      Options.</h2>

      <p><b>Introduction.</b> Balanitis Xerotica Obliterans was
      first described by St&uuml;hmer in 1928 in Germany.<sup><a
      href="#n1">1</a></sup> <i>Balanitis Xerotica Obliterans</i>
      (BXO) and <i>Lichen Sclerosus et Atrophicus</i> (LSA) are two
      names for the same disease.<sup><a
      href="#n2">2-3,21,32</a></sup> BXO/LSA is a skin disease of
      unknown etiology.<sup><a href="#n2">2</a></sup> It occurs in
      both males and females. LSA is the name applied when the
      disease appears in a female or a male in other than the
      genital organs. BXO is the name traditionally used when the
      disease afflicts the male sexual organs. An older name is
      <i>kraurosis glandii et praeputii penis</i>.<sup><a
      href="#n2">2,6</a></sup> This page is limited to information
      about the disease in males when it affects the genital
      organs. For information on the disease in females see <a
      href="http://www.emedicine.com/derm/topic234.htm"
      target="_blank">Lichen Sclerosus</a>.</p>

      <p>BXO is a rare disease that affects only 6 of 1000 males
      (.6 of 1 percent).<sup><a href="#n21">21</a></sup> It can
      affect males of any age.<sup><a href="#n21">21</a></sup> The
      traditional treatment has been radical circumcision.<sup><a
      href="#n16">16</a></sup> However, many conservative treatment
      options are now available.</p>

      <p><img src="bxo1.gif" alt="photo" align="right" />
      <b>Diagnosis.</b> <a
      href="/library/treatment/BXO/freeman1/">Freeman and
      Laymon</a> (1941) provide a detailed classic description of
      the disease:<sup><a href="#n2">2</a></sup> BXO is usually
      distinguished by a ring of hardened tissue with a whitish
      color at the tip of the foreskin. The hardening of the tissue
      prevents retraction of the foreskin.<sup><a
      href="#n23">23</a></sup> Immunophenotyping may be useful in
      differential diagnosis.<sup><a href="#n15">15</a></sup>
      Histologic examination of cutaneous biopsy gives a definite
      diagnosis.<sup><a href="#n7">7,8,23,27</a></sup> If the
      biopsy rules out BXO as a cause of non-retractile foreskin,
      then <a href="/library/treatment/phimosis/">conservative
      treatment</a> is most likely possible. On the other hand, if
      the biopsy confirms the presence of BXO, the choice of
      treatment modality is more difficult.</p>

      <p>BXO is a relatively serious disease. It can cause urethral
      stricture and retention of urine.<sup><a
      href="#n2">2</a></sup> Malignant tumors have (rarely) been
      reported to develop from BXO.<sup><a
      href="#n2">2,23</a></sup> Meffert <i>et al.</i> provide a
      recent review of the literature.<sup><a
      href="#n17">17</a></sup> A person with BXO or suspected BXO
      should be under the care of a medical doctor.</p>

      <p><b>Conventional vs. Conservative treatment.</b>
      Conventional medical wisdom has stated that BXO is an
      absolute indication for circumcision.<sup><a
      href="#n16">16</a></sup> However, that treatment modality
      dates from a time when the prepuce was considered to have no
      value for the individual. Clearly this is no longer the case.
      The <a href="/library/anatomy/cold-taylor/">function and
      value of the prepuce</a> is now recognized, and protection of
      the individual from unnecessarily radical surgery is always a
      doctor's prerogative. Fortunately, researchers have reported
      some success with conservative therapies for BXO that
      preserve the prepuce.</p>

      <p><b>Medical treatment.</b> Corticosteroids have been used
      with varying degrees of success.<sup><a
      href="#n4">4,5</a></sup>. <a
      href="/library/treatment/BXO/pasieczny1/">Pasieczny</a>
      reports successful treatment with topical testosterone
      propionate ointment.<sup><a href="#n7">7,26</a></sup> Several
      authorities report success with clobetasol propionate.<sup><a
      href="#n14"></a></sup>14,19,22,24 <a
      href="/library/treatment/BXO/shelley1/">Shelley and
      colleagues</a> report successful treatment with
      antibiotics.<sup><a href="#n25">25</a></sup> <a
      href="/library/treatment/BXO/depasquale1/">Depasquale and
      colleagues</a>, however, recommend radical circumcision, but
      also suggest mometasone or clobetasol cream as a medical
      treatment.<sup><a href="#n27">27</a></sup> Dewan reports that
      BXO is successfully treated with topical steroid ointment
      during the early stages.<sup><a href="#n30">30</a></sup>
      <sup><a href="#n31">31</a></sup> Assmann <i>et al.</i> report
      that tacrolimus ointment is effective for treatment of LSA in
      women.<sup><a href="#n32">32</a></sup> Clinical experience
      has shown it to be effective against BXO in boys. Ebert <i>et
      al.</i> report safety and good results with the use with
      Tacrolimus ointment.<sup><a href="#n38">38</a></sup></p>

      <p><b>Surgical treatment.</b> Carbon dioxide (CO<sub>2</sub>)
      laser surgery has been used with reported good
      results.<sup><a href="#n9">9,10,11,13,20</a></sup> A carbon
      dioxide laser is used to vaporize the lesions. Circumcision
      is the conventional radical surgical treatment but sacrifices
      the prepuce.<sup><a href="#n8">8,23,24,26,27</a></sup></p>

      <p><b>Conclusion.</b> There still seems to a wide range of
      opinion on the best treatment modalities for BXO. The cause
      is still unknown, although <a
      href="/library/treatment/BXO/shelley1/">Shelley <i>et
      al</i>.</a> hypothesize spirochete infection.<sup><a
      href="#n24">24</a></sup> More research is needed. Now,
      however, there is a good possibility of successful treatment
      without radical circumcision.<sup><a
      href="#n29">29</a></sup></p>

      <p>The trend today seems to be for greater use of medical
      treatment and less use of radical surgery in the treatment of
n      BXO.</p>

      <p><i>Library holdings are indexed in approximate
      chronological order of publication.</i></p>

      <p><b>Library holdings</b></p>

      <ol>
        <li><a id="n1" name="n1"></a><!--1-->St&uuml;hmer A.
        Balanitis xerotica obiterans und ihre Beziehungen zur
        'Kraurosis glandi et praeputii penis'. <i>Arch Dermatol
        Syph</i> (Berlin) 1928;156:613. DOI: 10.1007/BF01828558 [<a
        href="http://www.springerlink.com/content/k2895227m2410756/"
         target="_blank">Abstract</a>]</li>

        <li><a id="n2" name="n2"></a><!--2-->Freeman C, Laymon CW.
        <a href="/library/treatment/BXO/freeman1/">Balanitis
        xerotica obliterans</a>. <i>Arch Dermat Syph</i> (Chicago)
        1941;44;(4):547-559.</li>

        <li><a id="n3" name="n3"></a><!--3-->Laymon CW, Freeman C.
        <a href="/library/treatment/BXO/laymon1/">Relationship of
        Balanitis xerotica obliterans to lichen sclerosus et
        atrophicus</a>. <i>Arch Derm Syph</i> (Chicago) 1944: 49;
        57-59.</li>

        <li><a id="n4" name="n4"></a><!--4-->Catterall RD, Oakes
        JK. Treatment of balanitis xerotica obiterans with
        hydrocortisone injections. <i>Br J Ven Dis</i>
        1962;38:75.</li>

        <li><a id="n5" name="n5"></a><!--5-->Poynter JH. Levy J.
        Balanitis xerotica obliterans: effective treatment with
        topical and sublesional corticosteroids. <i>Br J Urol</i>
        1967;39(4):420-5.</li>

        <li><a id="n6" name="n6"></a><!--6-->McKay DL Jr, Fuqua F,
        Weinberg AG. <a
        href="/library/treatment/BXO/mckay1/">Balanitis xerotica
        obliterans in children</a>. <i>J Urol</i>
        1975;114(5):773-5.</li>

        <li><a id="n7" name="n7"></a><!--7--> Pasieczny TAH. <a
        href="/library/treatment/BXO/pasieczny1/">The treatment of
        balanitis xerotica obliterans with testosterone propionate
        ointment</a>. <i>Acta Derm Venerol</i> (Stockholm)
        1977;57:275-277.</li>

        <li><a id="n8" name="n8"></a><!--8--> Rickwood AMK,
        Hemalatha V, Batcup G, Spitz L. <a
        href="/library/treatment/phimosis/rickwood/">Phimosis in
        Boys.</a> <i>Brit J Urol</i> 1980; 52:147-150.</li>

        <li><a id="n9" name="n9"></a><!--9-->Rosemberg SK, Jacobs
        H. Continuous wave carbon dioxide treatment of balanitis
        xerotica obliterans. <i>Urology</i> 1982;19(5):539-41.</li>

        <li><a id="n10" name="n10"></a><!--10-->Ratz JL. <a
        href="/library/treatment/BXO/ratz1/">Carbon dioxide laser
        treatment of balanitis xerotica obliterans</a>. <i>J Am
        Acad Dermatol</i> 1984;10:925-28.</li>

        <li><a id="n11" name="n11"></a><!--11-->Rosemberg SK. <a
        href="/library/treatment/BXO/rosemberg1/">Carbon dioxide
        laser treatment of external genital lesions</a>.
        <i>Urology</i> 1985;25(6):555-8.</li>

        <li><a id="n12" name="n12"></a><!--12-->Bale PM, Lochhead
        A, Martin HC, Gollow I. <a
        href="/library/treatment/BXO/bale1/">Balanitis xerotica
        obliterans in children</a>. <i>Pediatr Pathol</i>
        1987;7(5-6):617-27.</li>

        <li><a id="n13" name="n13"></a><!--13-->Windahl T, Hellsten
        S. <a href="/library/treatment/BXO/windahl1/">Carbon
        dioxide laser treatment of lichen sclerosus et
        atrophicus</a>. <i>J Urol</i> 1993;150:868-70.</li>

        <li><a id="n14" name="n14"></a><!--14-->J&oslash;rgensen
        ET, Svensson &Aring;. <a
        href="/library/treatment/phimosis/jorgensen/">The treatment
        of phimosis in boys, with a potent topical steroid
        (clobetasol propionate 0,05%) cream</a>. <i>Acta
        Dermato-Venereologica</i> (Stockholm)
        1993;73(1):55-56.</li>

        <li><a id="n15" name="n15"></a><!--15-->Hinchliffe SA,
        Ciftci AO, Khine MM, et al. <a
        href="/library/treatment/BXO/hinchliffe1/">Composition of
        the inflammatory infiltrate in pediatric penile lichen
        sclerosus et atrophicus (balanitis xerotica obliterans): a
        prospective, comparative immunophenotyping study</a>.
        <i>Pediatr Pathol</i> 1994;14(2):223-33.</li>

        <li><a id="n16" name="n16"></a><!--16-->Meuli M, Briner J,
        Hanimann B, Sacher P. <a
        href="/library/treatment/phimosis/meuli/">Lichen sclerosus
        et atrophicus causing phimosis in boys: a prospective study
        with 5-year followup after complete circumcision</a>. <i>J
        Urol</i> 1994:152(3):987-9.</li>

        <li><a id="n17" name="n17"></a><!--17-->Meffert JJ, Davis
        BM, Grimwood RE. <a
        href="/library/treatment/BXO/meffert1/">Lichen
        Sclerosus</a>. <i>J Am Acad Dermatol</i>
        1995;32(3):393-416.</li>

        <li><a id="n18" name="n18"></a><!--18-->Hrebinko RL. <a
        href="/library/treatment/BXO/hrebinko1/">Circumferential
        laser vaporization for severe meatal stenosis secondary to
        balanitis xerotica obliterans</a>. <i>J Urol</i>
        1996;156(5):1735-6.</li>

        <li><a id="n19" name="n19"></a><!--!19-->Jorgensen ET,
        Svensson A. <a
        href="http://www.bmj.com/cgi/content/full/313/7058/692"
        target="_blank">Problems with the penis and prepuce in
        children: Lichen sclerosus should be treated with
        corticosteroids to reduce need for surgery</a>. <i>BMJ</i>
        1996;313:692. (link to www.bmj.com)</li>

        <li><a id="n20" name="n20"></a><!--20-->Kartamaa M, Reitamo
        S. <a href="/library/treatment/BXO/kartamaa1/">Treatment of
        lichen sclerosus with carbon dioxide laser
        vaporization</a>. <i>Br J Dermatol</i> 1997;136:356-9.</li>

        <li><a id="n21" name="n21"></a><!--21-->Parsad D, R. Saini
        R. <a href="http://www.vulvarpain.icomm.ca/parsad.html"
        target="_blank">Oral Stanozolol in Lichen Sclerosus et
        Atrophicus</a>. <i>J Am Acad Dermatol</i> 1998; 38( 2) part
        1: 278-9. (link to www.vulvarpain.icom.ca)</li>

        <li><a id="n22" name="n22"></a><!--22-->Dahlman-Ghozlan K,
        Hedblad MA, von Krogh G. <a
        href="/library/treatment/BXO/dahlman-ghozlan1/">Penile
        lichen sclerosus et atrophicus treated with clobetasol
        dipropionate 0.05% cream: a retrospective clinical and
        histopathological study</a>. <i>J Am Acad Dermatol</i>
        1999;40(3):451-7.</li>

        <li><a id="n23" name="n23"></a><!--23--> Shankar KR,
        Rickwood AM. <a
        href="/library/treatment/phimosis/shankar1/">The incidence
        of phimosis in boys</a>.<i>BJU Int</i>
        1999;84(1):101-2.</li>

        <li><a id="n24" name="n24"></a><!--24-->Neuhaus IM,
        Skidmore RA. <a
        href="http://www.familypractice.com/references/referencesframe.htm?main=/journal/1999/v12.n06/1206.06/art-1206.06.htm"
         target="_blank">Balanitis xerotica obliterans and its
        differential diagnosis</a>. <i>J Am Board Fam Pract</i>
        1999; 12(6):473-476.</li>

        <li><a id="n25" name="n25"></a><!--25-->Shelley, WB,
        Shelley ED, Gruenwald MA, et al. <a
        href="/library/treatment/BXO/shelley1/">Long-term
        antibiotic therapy for balanitis xerotica obliterans</a>.
        <i>J Am Acad Dermatol</i> 1999;40:69-72.</li>

        <li><a id="n26" name="n26"></a><!--26-->Rickwood AMK.
        Medical indications for circumcision. <i>BJU Int</i> 1999:
        83 Suppl 1, 45-51.</li>

        <li><a id="n27" name="n27"></a><!--27-->Depasquale I, Park
        AJ, Bracka A. <a
        href="/library/treatment/BXO/depasquale1/">The treatment of
        balanitis xerotica obliterans</a>. <i>BJU Int</i>
        2000;86(4):459-465.</li>

        <li><a id="n28" name="n28"></a><!--28-->Rickwood AMK, Kenny
        SE, Donnell SC. <a
        href="http://www.bmj.com/cgi/content/full/321/7264/792">Towards
        evidence based circumcision of English boys: survey of
        trends in practice.</a> <i>BMJ</i> 2000;321:792-793.</li>

        <li><a id="n29" name="n29"></a><!--29-->Dalton JD. <a
        href="http://bmj.com/cgi/eletters/321/7264/792#10014">BXO
        does not require treatment by circumcision</a>. (letter)
        <i>BMJ</i> 2000; rapid response pages.</li>

        <li><a id="n30" name="n30"></a><!--30-->Kiss A, Csontai A,
        Pirot L, <i>et al.</i> <a
        href="/library/treatment/BXO/kiss1/">The response of
        balanitis xerotica obliterans to local steroid application
        compared with placebo in children</a>. <i>J Urol</i>
        2001;165(1):219-20.</li>

        <li><a id="n31" name="n31"></a><!--31-->Neill SM, Tatnall
        FM, Cox NH. <a href="neill2002/">Guidelines for the
        management of lichen sclerosus</a>. <i>Br J Dermatol</i>
        2002;147:640-9.</li>

        <li><a id="n32" name="n32"></a><!--32-->Finkbeiner AE. <a
        href="finkbeiner2003/">Balanitis xerotica obliterans: a
        form of lichen sclerosus</a>. <i>South Med J</i>
        2003;96(1):7-8.</li>

        <li><a id="n33" name="n33"></a><!--33-->Kizer WS, Prairie
        T, Morey AF. <a href="kizer2003/">Balanitis xerotica
        obliterans: epidemiologic distribution in an equal access
        health care system</a>. <i>South Med J</i>
        2003;96(1):9-11.</li>

        <li><a id="n34" name="n34"></a>Dewan PA. <a
        href="http://www.mja.com.au/public/issues/178_04_170203/dew10610_fm.html"
         target="_blank">Treating Phimosis</a>. <i>Med J Aust</i>
        2003;178 (4):148-150.</li>

        <li><a id="n35" name="n35"></a>Assmann T, Becker-Wegerich
        P, Grewe M, <i>et al.</i> <a
        href="/library/treatment/BXO/assmann1/">Tacrolimus ointment
        for the treatment of vulvar lichen sclerosis</a>. <i>J Am
        Acad Dermatol</i> 2003;48(6):935-7.</li>

        <li><a id="n36" name="n36"></a>Gargollo PC, Kozakewich HP,
        Bauer SB, <i>et al.</i> <a href="gargollo2005/">Balanitis
        xerotica obliterans in boys</a>. <i>J Urol</i>
        2005;174:1409-12.</li>

        <li><a id="n37" name="n37"></a>Vincent MV, MacKinnon E. <a
        href="vincent2005/">The response of clinical balanitis
        xerotica obliterans to the application of topical
        steroid-based creams</a>. <i>J Pediatr Surg</i>
        2005;40(4):709&ndash;12.</li>

        <li><a id="n38" name="n38"></a>Ebert AK, Vogt T, R&ouml;sch
        WH. <a href="ebert2007/">[Topical therapy of balanitis
        xerotica obliterans in childhood: Long-term clinical
        results and an overview.]</a> <i>Urologe A.</i>
        2007;46(12):1682-6.</li>

        <li><a id="n39" name="n39"></a>Pugliese JM, Morey AF,
        Peterson AC. <a href="pugliese2007/">Lichen sclerosus:
        review of the literature and current recommendations for
        management</a>. <i>J Urol</i> 2007;178:2268-76.
        doi:10.1016/j.juro.2007.08.024</li>

        <li><a id="n40" name="n40" /> Poindexter G, Morrell DS. <a
        href="poindexter2007/">Anogenital pruritus: lichen
        sclerosus in children</a>. <i>Pediatr Ann</i>
        2007;36(12):785-91.</li>
      </ol>
      <hr size="1" color="black" />

      <blockquote>
        <h3>Medical Photographs</h3>

        <p>Family Practice offers a <a
        href="http://www.familypractice.com/references/referencesframe.htm?main=/journal/1999/v12.n06/1206.06/fig1-1206.06.htm">
        photograph</a> of BXO. (link to www.familypractice.com)</p>
      </blockquote>
    </div>
    <hr />
    <small>(File revised 10 March 2008)</small> 

    <p align="center"><a href="/library/">Return to CIRP
    library</a></p>

    <p><tt>http://www.cirp.org/library/treatment/BXO/</tt></p>
  </body>
</html>
